- Beyond the Hype: How AI is Being Used in Pharmacy (And What’s Coming Next)
- 16 hospitals earn Healthgrades’ ‘triple crown’
- 80 top hospitals for patient experience, safety: Healthgrades
- 373 top hospitals for patient experience: Healthgrades
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- Entry-level hiring drops at top employers: LinkedIn
- Ascension Texas hospital names chief clinical officer
- Building winning digital health strategies for patient-centered care — Lessons from 3 health systems
- How AI is enhancing pediatric dentistry
- Advocate Health speeds up prior authorizations with AI: 5 notes
- The best CEOs say these 3 words: ‘I don’t know’
- Women CIOs leading major health systems
- Henry Ford Health to receive $12M suicide prevention grant
- The broken pipeline of mental healthcare for LGBTQ teenagers
- Colonoscopy lowers CRC incidence but not mortality: Study
- AMA-backed bill targets No Surprises Act enforcement
- Michigan surgeon completes 1st US knee replacement with AR glasses
- Where orthopedic care could go wrong over the next decade
- Optum-affiliated New York practice to close
- Pennsylvania dental group suffers data breach
- The state of the CAA workforce in 2026
- The anesthesia billing mistakes costing ASCs the most
- US Bank launches loan for startup dental practices
- New Ohio dental school gets $500K gift
- The ‘grit’ required for outpatient cardiology
- Novant hospital’s pediatric behavioral ED stays drop from 6 weeks to 2.11 days
- Oregon ASC to close after acquisition collapses amid state review
- 12 dentists making headlines
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- What the shifting private practice landscape means for new dentists
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- VA to expand virtual reality therapy initiative
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Why orthopedic surgeons are pushing back on noncompetes
- New York hospital to add psychiatric emergency program
- U of Missouri opens $54.8M autism care facility
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- Why new dentists must rethink private practice
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Could autism care benefit from more therapy choices?
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- Watch: 8 Health Insurance Terms You Should Know
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- Lone Peak Dental Group acquires Arizona practice
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- Maine behavioral health provider cites industry pressures in merger
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- VR Training Helps Autistic People Navigate Police Encounters
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
Astounding.
We have an insulin shortage, so our our legislature proposes Bills 1 and 2 - replete with perhaps the only thing that could make the insulin market worse: more government involvement.
And see the final agenda item, sending EMS bill to the committee on government operations?
Emergency Medical Services (EMS) were placed under MDHHS control by the Snyder administration. Not only does MMDHS control EMS licensing, testing, and education qualifications, but it also governs the regional EMS command and control power structure that sets practices (removing legal liability) and directs personnel in the field.
It's like a paramilitary organization, all under the label of health.
Wednesday, February 28, 2024
TIME: 12:15 PM or after committees are given leave by the House to meet, whichever time is later.AGENDA:
Presentation on Diabetes.
HB 4890 (Rep. VanderWall)
Health; pharmaceuticals; insulin production program; establish.HB 5519 (Rep. Conlin)
Economic development; Michigan strategic fund; insulin production program; include in report of activities.Refer to the House Committee on Government Operations:
SB 249 (Sen. Hertel)
Health occupations; emergency medical services personnel; examinations for certain emergency medical services personnel; modify, and require certain notices from education program sponsors.OR ANY BUSINESS PROPERLY BEFORE THIS COMMITTEE
California tried this back in 2020. Gov. Newsom announced a state insulin manufacturing project, and CA passed a law the same year. Insulin production was projected to begin as soon as early 2024, but despite frequent headlines in 2023 and a website ready to sell - nada.
For this and the following reasons, diabetics probably won't want to hold their breath for Michigan insulin.
Despite ongoing shortages, Crain's Detroit recently published, "Should Michigan get into the insulin business? Dropping market prices could thwart plan." The article is behind a paywall, but the title alone says a lot.
I'm still seeing $150-$300+ per vial on GoodRX, but they agree there's been a drop of approximately 10%.
Why is the price of insulin dropping?
President Biden and Congress would like to credit Medicare price caps and other federal policy changes.
BUT - and as a dairy farmer's daughter I absolutely love this - Science Alert has a far more entertaining explanation.
Good old competition from the world of agricultural research!
https://www.sciencealert.com/scientists-engineer-cow-that-makes-human-insulin-proteins-in-its-milk
Scientists Engineer Cow That Makes Human Insulin Proteins in Its Milk
18 March 2024 | ByJESS COCKERILLA genetically modified cow has produced proteins needed for human insulin in its milk, and the scientists behind the experiment have high hopes that a herd of these cattle could solve the world's insulin supply problems.
If such a herd were viable – and, based on this first case, that's still a long way off – the researchers think it could out-compete current insulin production methods, which rely on genetically modified yeast and bacteria.
http://www.gene.com/media/press-releases/4160/1978-09-06/first-successful-laboratory-production- o">Insulin – and its role in diabetes – was first discovered in 1921, and for many years diabetics were treated with insulin sourced from the pancreases of cattle and pigs.
But in 1978, the first 'human' insulin was produced using proteins from genetically engineered E. coli bacteria, which, along with similar processes that use yeast instead of bacteria, is the main source of medical insulin to this day.
While turning to cows for human insulin supply isn't new, the new study is the first time 'human' insulin production has been achieved in a genetically modified bovine.
The research team, led by animal scientist Matt Wheeler from the University of Illinois Urbana-Champaign, inserted a particular segment of human DNA that codes for proinsulin (a protein that's converted to insulin) into the cell nuclei of 10 cow embryos, which were then inserted into the wombs of normal cows.
Only one of these genetically modified embryos developed into a pregnancy, leading to the natural birth of a living, transgenic calf.
When it reached maturity, the team made a variety of attempts to get the genetically modified cow pregnant, by artificial insemination, in vitro fertilization, and even the old-fashioned way. None were successful, but the team notes this may be more to do with how the embryo was created than the fact it was genetically modified.
Eventually they were able to get the cow to lactate via hormonal induction, using an undisclosed method attributed to animal reproduction technologist Pietro Baruselli from the University of São Paulo.
The cow didn't lactate as much as it would during a pregnancy, but what little milk it did produce over a month was examined to look for specific proteins, using western blotting and mass spectrometry.
The blotting revealed two bands with similar molecular masses to human proinsulin and insulin, which were not present in the milk of non-transgenic cows. Mass spectrometry indicated the presence of the C-peptide that's removed from human proinsulin in the process of creating insulin, which suggests that enzymes in the cow's milk may have converted the 'human' proinsulin into insulin.
"Our goal was to make proinsulin, purify it out to insulin, and go from there. But the cow basically processed it herself. She makes about three to one biologically active insulin to proinsulin," Wheeler says.
In 2014, a similar kind of genetic modification was achieved in mice, whose milk contained up to 8.1 grams per liter of human proinsulin. Comparable concentrations were not reported in this new study, but that hasn't stopped Wheeler from thinking about scaling up.
A typical unit of insulin is 0.0347 milligrams, so if, as Wheeler proposes, each cow could make one gram of insulin per liter of milk, that's 28,818 units of insulin.
"You'd need specialized, high-health-status facilities for the cattle, but it's nothing too out of the ordinary for our well-established dairy industry," he says.
"I could see a future where a 100-head herd… could produce all the insulin needed for the country. And a larger herd? You could make the whole world's supply in a year."
This research was published in Biotechnology Journal.
Like most expensive products, high insulin prices will last only as long as Big Pharma can lobby to extend patent protection and otherwise block competition from generic knock-offs.
And it's not just insulin, but all biologic (cell-based) drugs. Some of them for cancer, rheumatoid arthritis, and other diseases cost thousands of dollars per dose.
It's pretty amazing how far manufacturers will go to keep your pharmacist from substituting biologic equivalents for originals like Lantus, Humalog, etc.
I testified against Big Pharma efforts to erect Michigan state legal barriers to "generic" biologics in 2018. The rest of that story is here.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















